Acuta Capital Partners as of March 31, 2020
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 32 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Flamel Technologies Sa (AVDL) | 10.2 | $21M | 2.7M | 7.84 | |
| Axsome Therapeutics (AXSM) | 8.8 | $18M | 309k | 58.83 | |
| Adverum Biotechnologies | 8.1 | $17M | 1.7M | 9.77 | |
| Iovance Biotherapeutics (IOVA) | 5.8 | $12M | 400k | 29.93 | |
| Arvinas Ord (ARVN) | 5.5 | $11M | 280k | 40.30 | |
| Aurinia Pharmaceuticals (AUPH) | 5.4 | $11M | 770k | 14.51 | |
| Bellus Health | 5.2 | $11M | 1.1M | 9.98 | |
| Kadmon Hldgs | 4.8 | $9.9M | 2.4M | 4.19 | |
| Verastem | 4.6 | $9.5M | 3.7M | 2.55 | |
| Xenon Pharmaceuticals (XENE) | 3.5 | $7.1M | 629k | 11.34 | |
| Ascendis Pharma A S (ASND) | 3.4 | $7.1M | 63k | 112.61 | |
| Bioxcel Therapeutics (BTAI) | 3.4 | $7.0M | 315k | 22.35 | |
| Catalyst Biosciences | 2.9 | $6.1M | 1.4M | 4.37 | |
| Selecta Biosciences (RNAC) | 2.8 | $5.7M | 2.4M | 2.41 | |
| Apellis Pharmaceuticals (APLS) | 2.7 | $5.6M | 210k | 26.79 | |
| Lifesci Acquisition Corp unit 03/31/2025 | 2.7 | $5.6M | 560k | 10.00 | |
| Mersana Therapeutics (MRSN) | 2.3 | $4.8M | 828k | 5.83 | |
| Dicerna Pharmaceuticals | 2.3 | $4.7M | 257k | 18.37 | |
| Constellation Pharmceticls I | 2.1 | $4.4M | 140k | 31.43 | |
| Karuna Therapeutics Ord | 2.0 | $4.0M | 56k | 72.00 | |
| Reata Pharmaceuticals Inc Cl A | 1.6 | $3.4M | 24k | 144.34 | |
| Applied Therapeutics (APLT) | 1.6 | $3.3M | 102k | 32.69 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.5 | $3.2M | 110k | 28.77 | |
| Relmada Therapeutics (RLMD) | 1.5 | $3.1M | 91k | 34.11 | |
| Uniqure Nv (QURE) | 1.2 | $2.5M | 53k | 47.45 | |
| Marinus Pharmaceuticals | 1.0 | $2.1M | 1.0M | 2.03 | |
| Global Blood Therapeutics In | 1.0 | $2.0M | 39k | 51.10 | |
| Kura Oncology (KURA) | 1.0 | $2.0M | 198k | 9.95 | |
| Zafgen | 0.5 | $1.1M | 1.4M | 0.77 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $500k | 250k | 2.00 | |
| Iveric Bio | 0.2 | $478k | 139k | 3.44 | |
| Arbutus Biopharma (ABUS) | 0.1 | $273k | 270k | 1.01 |
